Pharmacokinetic Profile of the Isoflavone Puerarin After Acute and Repeated Administration of a Novel Kudzu Extract to Human Volunteers
Overview
Affiliations
Objectives: This study was undertaken to assess the pharmacokinetic profile of puerarin, the major isoflavone found in a kudzu (Pueraria lobata) extract after acute and repeated administration.
Methods: Participants were given either single or repeated doses of kudzu extract, and blood samples were collected for either 8 or 72 hours for subsequent pharmacokinetic analyses of puerarin.
Results: Using WinNonlin pharmacokinetic data analysis software, puerarin was found to be rapidly absorbed via the oral route, reach peak levels at 2 hours, and have a half-life of approximately 4.3 hours. The elimination half-life was not significantly altered after repeated administration.
Conclusions: A formulation of kudzu extract delivers a large amount of the principal isoflavone in a rapid manner. The elimination rate constants and the mono-exponential decline in blood levels suggest that a one compartment model adequately explains how puerarin is handled by the body. Three times a day dosing is recommended as accumulation will not occur, and plasma levels remain at levels that are biologically active, even 8 hours after the last steady-state dose.
Bihlet A, Byrjalsen I, Andersen J, Simonsen S, Mundbjerg K, Helmer B Front Pharmacol. 2021; 12:760629.
PMID: 34744740 PMC: 8568880. DOI: 10.3389/fphar.2021.760629.
Houriet J, Arnold Y, Pellissier L, Kalia Y, Wolfender J Metabolites. 2021; 11(8).
PMID: 34436482 PMC: 8398828. DOI: 10.3390/metabo11080541.
A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm.
Penetar D, Toto L, Lee D, Lukas S Drug Alcohol Depend. 2015; 153:194-200.
PMID: 26048637 PMC: 4510012. DOI: 10.1016/j.drugalcdep.2015.05.025.
Lukas S, Penetar D, Su Z, Geaghan T, Maywalt M, Tracy M Psychopharmacology (Berl). 2012; 226(1):65-73.
PMID: 23070022 PMC: 3562758. DOI: 10.1007/s00213-012-2884-9.
The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study.
Penetar D, Toto L, Farmer S, Lee D, Ma Z, Liu Y Drug Alcohol Depend. 2012; 126(1-2):251-6.
PMID: 22578529 PMC: 3430804. DOI: 10.1016/j.drugalcdep.2012.04.012.